Petersen B, Yee C J, Bowen W, Zarnegar R, Michalopoulos G K
Department of Pathology, University of Pittsburgh, School of Medicine, PA 15261.
Cell Biol Toxicol. 1994 Aug;10(4):219-30. doi: 10.1007/BF00756762.
TGF-beta 1 is known as a potent inhibitor of proliferation of rat and human hepatocytes. In this study we show that the effects of TGF-beta 1 are quite different on mouse hepatocytes. In rat and human hepatocytes, TGF-beta 1 inhibited DNA synthesis and also inhibited the morphological changes induced by growth factors in rat and human hepatocytes. In contrast, addition of TGF-beta 1 to mouse hepatocytes resulted in pronounced alterations in morphology of these cells. These changes were similar to those induced by HGF and EGF. The induction of structural changes by TGF-beta 1 was noted only in mouse hepatocytes. Mouse hepatocytes were also much more resistant to the mito-inhibitory effect of TGF-beta 1. These findings suggest profound differences in hepatocyte growth regulation between these species and may relate to observed differences in susceptibility to carcinogenesis.
转化生长因子β1(TGF-β1)是一种已知的大鼠和人类肝细胞增殖的强效抑制剂。在本研究中,我们发现TGF-β1对小鼠肝细胞的作用截然不同。在大鼠和人类肝细胞中,TGF-β1抑制DNA合成,还抑制生长因子诱导的大鼠和人类肝细胞形态变化。相比之下,向小鼠肝细胞中添加TGF-β1会导致这些细胞形态发生明显改变。这些变化与肝细胞生长因子(HGF)和表皮生长因子(EGF)诱导的变化相似。TGF-β1诱导的结构变化仅在小鼠肝细胞中观察到。小鼠肝细胞对TGF-β1的线粒体抑制作用也更具抗性。这些发现表明这些物种之间肝细胞生长调节存在深刻差异,可能与观察到的致癌易感性差异有关。